Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205894 · ClinicalTrials.gov registry record · Phase 1
Occipital Nerve Stimulation to Treat Chronic Headaches
A Phase 1 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00205894 is a Phase 1 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 20 participants.
The verdict
NCT00205894, a Phase 1 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of a implantable device, called the bion(R), in the treatment of chronic headache. The bion microstimulator is placed underneath the skin next to the greater occipital nerve. The bion microstimulator then stimulates the nerve by generating small amounts of electrical current.
Interventions
- DEVICE bion microstimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205894
The ClinicalTrials.gov registry entry for NCT00205894 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bion microstimulator is the first listed.
NCT00205894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205894 about?
NCT00205894 is a clinical study titled "Occipital Nerve Stimulation to Treat Chronic Headaches". The purpose of this study is to evaluate the safety and efficacy of a implantable device, called the bion(R), in the treatment of chronic headache. The bion microstimulator is placed underneath the skin next to the greater occipital nerve. The bion microstimulator then stimulates the nerve by genera...
What is the current status of trial NCT00205894?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2004-01. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00205894?
The interventions under investigation include: bion microstimulator (DEVICE).
Who is sponsoring clinical trial NCT00205894?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.